Well, all I can say to that is...how does he know
It is still slowing gastric emptying
For someone already taking a GLP-1 medication, this reinforces the idea that obesity treatment is not cosmetic its a chronic disease treatment and risk-reduction medication. GLP-1s Users Had Lower Rates of Blood Clots, ER Visits, and Death The study analyzed health records from more than 26,000 adults with obesity and at least one autoimmune disease, such as rheumatoid arthritis, psoriatic arthritis, type 1 diabetes, vitiligo, and celiac disease
We found that combination therapy of linagliptin (LINA) to empagliflozin (EMPA), but not EMPA alone decreased phosphorylated Nedd4-2 (p-Nedd4-2) and ENaC levels in DKD rats in association with the increased urinary sodium excretion (USE)
Hydroquinone 4% is a Pregnancy Category C drug, with animal studies showing risks and insufficient human studies
CNT was calculated using the following formula: multiply drug costs (from an American drug discount website) and follow-up times, then divide by the average percentage of weight loss for each drug in comparison to placebo
